Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1612 | 2020 |
The evolutionary history of 2,658 cancers M Gerstung, C Jolly, I Leshchiner, SC Dentro, S Gonzalez, D Rosebrock, ... Nature 578 (7793), 122-128, 2020 | 907 | 2020 |
Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells M Sun, Z Estrov, Y Ji, KR Coombes, DH Harris, R Kurzrock Molecular cancer therapeutics 7 (3), 464-473, 2008 | 502 | 2008 |
MR imaging radiomics signatures for predicting the risk of breast cancer recurrence as given by research versions of MammaPrint, Oncotype DX, and PAM50 gene assays H Li, Y Zhu, ES Burnside, K Drukker, KA Hoadley, C Fan, SD Conzen, ... Radiology 281 (2), 382-391, 2016 | 501 | 2016 |
TCGA-assembler: open-source software for retrieving and processing TCGA data Y Zhu, P Qiu, Y Ji Nature methods 11 (6), 599-600, 2014 | 396 | 2014 |
Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set H Li, Y Zhu, ES Burnside, E Huang, K Drukker, KA Hoadley, C Fan, ... NPJ breast cancer 2, 16012, 2016 | 348 | 2016 |
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes SC Dentro, I Leshchiner, K Haase, M Tarabichi, J Wintersinger, ... Cell 184 (8), 2239-2254. e39, 2021 | 312 | 2021 |
Genomic heterogeneity as a barrier to precision medicine in gastroesophageal adenocarcinoma E Pectasides, MD Stachler, S Derks, Y Liu, S Maron, M Islam, L Alpert, ... Cancer discovery 8 (1), 37-48, 2018 | 284 | 2018 |
A modified toxicity probability interval method for dose-finding trials Y Ji, P Liu, Y Li, B Nebiyou Bekele Clinical trials 7 (6), 653-663, 2010 | 268 | 2010 |
Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial A Younes, Y Oki, RG Bociek, J Kuruvilla, M Fanale, S Neelapu, ... The lancet oncology 12 (13), 1222-1228, 2011 | 221 | 2011 |
TCGA-assembler 2: software pipeline for retrieval and processing of TCGA/CPTAC data L Wei, Z Jin, S Yang, Y Xu, Y Zhu, Y Ji Bioinformatics 34 (9), 1615-1617, 2018 | 213 | 2018 |
Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios G Yin, Y Li, Y Ji Biometrics 62 (3), 777-787, 2006 | 198 | 2006 |
Modified toxicity probability interval design: a safer and more reliable method than the 3+ 3 design for practical phase I trials Y Ji, SJ Wang Journal of Clinical Oncology 31 (14), 1785-1791, 2013 | 188 | 2013 |
Gemcitabine pharmacogenomics: cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics JA Gilbert, OE Salavaggione, Y Ji, LL Pelleymounter, BW Eckloff, ... Clinical Cancer Research 12 (6), 1794-1803, 2006 | 184 | 2006 |
Preemptive pharmacogenomic testing for precision medicine: a comprehensive analysis of five actionable pharmacogenomic genes using next-generation DNA sequencing and a … Y Ji, JM Skierka, JH Blommel, BE Moore, DL VanCuyk, JK Bruflat, ... The Journal of Molecular Diagnostics 18 (3), 438-445, 2016 | 182 | 2016 |
Deciphering genomic underpinnings of quantitative MRI-based radiomic phenotypes of invasive breast carcinoma Y Zhu, H Li, W Guo, K Drukker, L Lan, ML Giger, Y Ji Scientific reports 5 (1), 17787, 2015 | 179 | 2015 |
Glycine and a Glycine Dehydrogenase (GLDC) SNP as Citalopram/Escitalopram Response Biomarkers in Depression: Pharmacometabolomics‐Informed … Y Ji, S Hebbring, H Zhu, GD Jenkins, J Biernacka, K Snyder, M Drews, ... Clinical Pharmacology & Therapeutics 89 (1), 97-104, 2011 | 176 | 2011 |
Recommendations for clinical CYP2C19 genotyping allele selection: a report of the Association for Molecular Pathology VM Pratt, AL Del Tredici, H Hachad, Y Ji, LV Kalman, SA Scott, KE Weck The Journal of Molecular Diagnostics 20 (3), 269-276, 2018 | 175 | 2018 |
Applications of beta-mixture models in bioinformatics Y Ji, C Wu, P Liu, J Wang, KR Coombes Bioinformatics 21 (9), 2118-2122, 2005 | 173 | 2005 |
Synchronous selection of homing peptides for multiple tissues by in vivo phage display. MG Kolonin, J Sun, KA Do, CI Vidal, Y Ji, KA Baggerly, R Pasqualini, ... FASEB journal 20 (7), 2006 | 168 | 2006 |